Connection

Jean-Jacques Tuech to Chemoradiotherapy, Adjuvant

Back to Details
This is a "connection" page, showing publications Jean-Jacques Tuech has written about Chemoradiotherapy, Adjuvant.
Jean-Jacques Tuech
Connection Strength
0.042
Chemoradiotherapy, Adjuvant
  1. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet. 2017 07 29; 390(10093):469-479.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.